未登录

C

Chitra Subramanian

university of illinois at urbana-champaign

H指数:28

被引数:2,508

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A novel therapeutic approach to adrenocortical carcinoma repurposing fingolimod to target sphingolipid metabolism in metastatic disease

一种新型肾上腺皮质癌治疗方法：重新利用 fingolimod 靶向转移性疾病中的鞘脂代谢

IF2.7

2025-10-230

OAAI

C-Terminal Hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma

C-末端Hsp90抑制剂克服黑色素瘤中MEK和BRAF抑制剂的耐药性

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

IF4.2

2025-03-260

OAAI

Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway

IF2.7

2025-01-010

OAAI

Chiroptical detection and mutation analysis of cancer-associated extracellular vesicles using microfluidics with oriented chiral nanoparticles

使用带有定向手性纳米颗粒的微流体技术对癌症相关细胞外囊泡的手性检测和突变分析

IF17.5

2024-12-010

OA

The Investigation of Hsp90C-Terminal Inhibitors Containing Amide Bioisosteres

IF3.4

2024-10-290

PRE

Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities

RSC MEDICINAL CHEMISTRY

IF3.6

2024-01-014

PRE

CryoEM Structure with ATP Synthase Enables Late-Stage Diversification of Cruentaren A

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2023-04-131

OA

Chiroptical detection and mutation analysis of cancer-associated extracellular vesicles in microfluidic devices with oriented chiral nanoparticles

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival

IF2.7

2023-01-016

OAAI

Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma

IF5

2022-12-192

OAAI

Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer

NATURE METABOLISM

IF20.8

2022-09-2118

PRE

Synthesis and Evaluation of Simplified Cruentaren A Analogues

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2022-07-271

PRE

Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics

IF2.7

2022-01-014

PRE

Re-Evaluation of Combinational Efficacy and Synergy of the Italian Protocol In Vitro: Are We Truly Optimizing Benefit or Permitting Unwanted Toxicity?

IF3.9

2021-09-101

OAAI

Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines (vol 77, pg 4261, 2003)

JOURNAL OF VIROLOGY

IF3.8

2021-07-120

OA

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

NATURE CELL BIOLOGY

IF19.1

2021-05-06112

OAAI

A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro

IF2.7

2021-01-0111

OAAI

Novel C-terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self-renewal, and epithelial-mesenchymal transition

MOLECULAR ONCOLOGY

IF4.5

2020-05-1515

OAAI

A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression

IF2.7

2020-01-015

OAAI

Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer

IF2.7

2019-12-0111

OAAI